Woodford Investment Management as of Dec. 31, 2016
Portfolio Holdings for Woodford Investment Management
Woodford Investment Management holds 7 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abbvie (ABBV) | 33.9 | $703M | 11M | 62.62 | |
| Prothena (PRTA) | 24.4 | $507M | 10M | 49.19 | |
| Alkermes (ALKS) | 19.9 | $414M | 7.5M | 55.58 | |
| Theravance Biopharma (TBPH) | 16.1 | $335M | 11M | 31.88 | |
| Biogen Idec (BIIB) | 3.1 | $65M | 249k | 261.21 | |
| Gilead Sciences (GILD) | 2.1 | $44M | 614k | 71.61 | |
| Northwest Biotherapeutics In (NWBO) | 0.4 | $8.7M | 25M | 0.35 |
